In this study, the TLR9, MyD88, and NF-κB p65 in peripheral blood of active SLE patients were determined, and their correlation with SLE immunological indicators and their clinical significance were analyzed to investigate the pathogenesis of SLE and provide a basis for the prevention and treatment of SLE. This evidence concerns the gene MYD88 and systemic lupus erythematosus.